Banco de Sabadell S.A Sells 10,443 Shares of UnitedHealth Group Inc (UNH)
Banco de Sabadell S.A lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 25.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,092 shares of the healthcare conglomerate’s stock after selling 10,443 shares during the period. UnitedHealth Group comprises approximately 1.0% of Banco de Sabadell S.A’s investment portfolio, making the stock its 22nd largest holding. Banco de Sabadell S.A’s holdings in UnitedHealth Group were worth $7,622,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in UNH. Summit Trail Advisors LLC boosted its position in UnitedHealth Group by 19,286.4% in the 1st quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after purchasing an additional 6,195,939 shares in the last quarter. FMR LLC lifted its position in shares of UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after buying an additional 2,981,233 shares in the last quarter. Vontobel Asset Management Inc. purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $404,980,000. Bank of Montreal Can purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $381,555,000. Finally, Janus Henderson Group PLC lifted its position in shares of UnitedHealth Group by 61.7% during the 2nd quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock valued at $864,869,000 after buying an additional 1,345,083 shares in the last quarter. Institutional investors and hedge funds own 85.30% of the company’s stock.
In related news, EVP D Ellen Wilson sold 15,393 shares of the stock in a transaction on Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the transaction, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is owned by corporate insiders.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.10. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The firm had revenue of $56.09 billion during the quarter, compared to the consensus estimate of $56.10 billion. During the same period in the prior year, the company earned $2.46 EPS. The firm’s revenue was up 12.1% compared to the same quarter last year. sell-side analysts forecast that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.
UnitedHealth Group declared that its board has approved a stock buyback plan on Wednesday, June 6th that permits the company to repurchase 100,000,000 shares. This repurchase authorization permits the healthcare conglomerate to purchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 1.37%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 35.75%.
A number of research analysts have recently issued reports on UNH shares. Morgan Stanley increased their target price on UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a research report on Wednesday, July 18th. Citigroup increased their target price on UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a research report on Wednesday, July 18th. Royal Bank of Canada increased their target price on UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a research report on Wednesday, July 18th. Goldman Sachs Group reiterated a “buy” rating and set a $277.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a research report on Sunday, July 15th. Two investment analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $275.87.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.